CIK 0001544227 · Non-accelerated filer<br>Smaller reporting company
Tempest Therapeutics, Inc.
Sign in to watch- Ticker
- TPST
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 451472564
- Phone
- 415-798-8589
- Business address
- 2000 SIERRA POINT PARKWAY, SUITE 400, BRISBANE, CA, 94005
- Former names
- Millendo Therapeutics, Inc., OvaScience, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-06-25 | RAAB MICHAEL Director | Grant or award · Stock Option (Right to Buy) | +16,784 | 16,784 | ||
| 2021-06-25 | RAAB MICHAEL Director | Grant or award · Stock Option (Right to Buy) | +9,660 | 9,660 | ||
| 2021-06-25 | RAAB MICHAEL Director | Grant or award · Stock Option (Right to Buy) | +4,830 | 4,830 | ||
| 2021-06-25 | Dubensky Thomas W. President | Grant or award | +111,343 | 111,343 | ||
| 2021-06-25 | Dubensky Thomas W. President | Grant or award · Stock Option (Right to Buy) | +36,263 | 36,263 | ||
| 2021-06-25 | Dubensky Thomas W. President | Grant or award · Stock Option (Right to Buy) | +45,988 | 45,988 | ||
| 2021-06-25 | Dubensky Thomas W. President | Grant or award · Stock Option (Right to Buy) | +8,050 | 8,050 | ||
| 2021-06-25 | Dubensky Thomas W. President | Grant or award · Stock Option (Right to Buy) | +1,000,000 | 1,000,000 | ||
| 2021-06-25 | Brady Stephen R Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +110,432 | 110,432 | ||
| 2021-06-25 | Brady Stephen R Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +70,256 | 70,256 | ||
| 2021-06-25 | Brady Stephen R Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +8,050 | 8,050 | ||
| 2021-06-25 | Brady Stephen R Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +1,982,250 | 1,982,250 | ||
| 2021-06-25 | Woiwode Thomas Director | Grant or award | +997,940 | 997,940 | ||
| 2021-06-25 | Woiwode Thomas Director | Grant or award | +1,171,094 | 1,171,094 | ||
| 2021-06-25 | Woiwode Thomas Director | Grant or award | +7,377 | 7,377 | ||
| 2021-06-25 | Lorenzo Pierre Corporate Controller | Grant or award | +53 | 53 | ||
| 2021-06-25 | Lorenzo Pierre Corporate Controller | Grant or award · Stock Option (Right to Buy) | +4,830 | 4,830 | ||
| 2021-06-25 | Lorenzo Pierre Corporate Controller | Grant or award · Stock Option (Right to Buy) | +1,234 | 1,234 | ||
| 2021-06-25 | Lorenzo Pierre Corporate Controller | Grant or award · Stock Option (Right to Buy) | +48,535 | 48,535 | ||
| 2021-03-17 | Owens Julia C. Executive Chair | Grant or award · Stock Option (right to buy) | +24,000 | 24,000 |
Page 5 of 6 · 119 trades